Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation

Dahlbäck, 2007, The tale of protein S and C4b-binding protein, a story of affection., Thromb Haemost, 98, 90 Griffin, 2012, Protein C anticoagulant and cytoprotective pathways., Int J Hematol, 95, 333, 10.1007/s12185-012-1059-0 Saller, 2009, Generation and phenotypic analysis of protein S-deficient mice., Blood, 114, 2307, 10.1182/blood-2009-03-209031 García de Frutos, 2007, Molecular basis of protein S deficiency., Thromb Haemost, 98, 543 Gómez, 1994, Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene., Thromb Haemost, 71, 723, 10.1055/s-0038-1642512 Hayashi, 1994, Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S., Blood, 83, 683, 10.1182/blood.V83.3.683.683 Yamazaki, 1993, A phenotypically neutral dimorphism of protein S: the substitution of Lys155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene., Thromb Res, 70, 395, 10.1016/0049-3848(93)90081-X Kinoshita, 2005, Protein S and protein C gene mutations in Japanese deep vein thrombosis patients., Clin Biochem, 38, 908, 10.1016/j.clinbiochem.2005.05.006 Kimura, 2006, Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients., Blood, 107, 1737, 10.1182/blood-2005-09-3892 Ikejiri, 2010, The association of protein S Tokushima-K196E with a risk of deep vein thrombosis., Int J Hematol, 92, 302, 10.1007/s12185-010-0671-0 Yin, 2014, Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians., J Thromb Thrombolysis, 37, 56, 10.1007/s11239-013-1005-x Kimura, 2006, Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers., J Thromb Haemost, 4, 2010, 10.1111/j.1538-7836.2006.02071.x Miyata, 2006, Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation., Int J Hematol, 83, 217, 10.1532/IJH97.A20514 Miyata, 2012, More on: racial differences in venous thromboembolism., J Thromb Haemost, 10, 319, 10.1111/j.1538-7836.2011.04578.x Neki, 2011, Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum., Int J Hematol, 94, 150, 10.1007/s12185-011-0902-z Miyata, 2009, Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis., Thromb Res, 124, 14, 10.1016/j.thromres.2008.08.020 Neki, 2014, Nonsynonymous mutations in three anticoagulant genes in Japanese patients with adverse pregnancy outcomes., Thromb Res, 133, 914, 10.1016/j.thromres.2014.02.012 Pecheniuk, 2008, Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry., Thromb Haemost, 99, 453, 10.1160/TH07-10-0607 Liu, 2013, Protein S K196E mutation, a genetic risk factor for venous thromboembolism, is limited to Japanese., Thromb Res, 132, 314, 10.1016/j.thromres.2013.05.008 Goldhaber, 2014, Race and venous thromboembolism: nature or nurture?, Circulation, 129, 1463, 10.1161/CIRCULATIONAHA.114.008799 Kujovich, 2011, Factor V Leiden thrombophilia., Genet Med, 13, 1, 10.1097/GIM.0b013e3181faa0f2 Dahlbäck, 2008, Advances in understanding pathogenic mechanisms of thrombophilic disorders., Blood, 112, 19, 10.1182/blood-2008-01-077909 Ridker, 1995, Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men., N Engl J Med, 332, 912, 10.1056/NEJM199504063321403 Cui, 2000, Spontaneous thrombosis in mice carrying the factor V Leiden mutation., Blood, 96, 4222, 10.1182/blood.V96.13.4222 Eitzman, 2005, Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice., Circulation, 111, 1822, 10.1161/01.CIR.0000160854.75779.E8 Kerlin, 2003, Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia., Blood, 102, 3085, 10.1182/blood-2003-06-1789 Wang, 2011, Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy., Blood, 117, 5231, 10.1182/blood-2010-10-314773 Burstyn-Cohen, 2009, Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis., J Clin Invest, 119, 2942, 10.1172/JCI39325 Okuda, 2004, Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves., Mol Cell Biol, 24, 3949, 10.1128/MCB.24.9.3949-3956.2004 Banno, 2006, Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura., Blood, 107, 3161, 10.1182/blood-2005-07-2765 Yamamoto, 2011, NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia., J Biol Chem, 286, 26158, 10.1074/jbc.M111.256446 Eura, 2012, Derlin-1 deficiency is embryonic lethal, Derlin-3 deficiency appears normal, and Herp deficiency is intolerant to glucose load and ischemia in mice., PLoS One, 7, e34298, 10.1371/journal.pone.0034298 Fernández, 2009, Species-specific anticoagulant and mitogenic activities of murine protein S., Haematologica, 94, 1721, 10.3324/haematol.2009.009233 Diaz, 2013, The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse., Thromb Haemost, 109, 1158, 10.1160/TH12-09-0711 Tashima, 2015, Influence of ADAMTS13 deficiency on venous thrombosis in mice., Thromb Haemost, 114, 206, 10.1160/TH14-08-0656 Smith, 2010, Polyphosphate exerts differential effects on blood clotting, depending on polymer size., Blood, 116, 4353, 10.1182/blood-2010-01-266791 Müller, 2009, Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo., Cell, 139, 1143, 10.1016/j.cell.2009.11.001 Yanamoto, 2003, Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique., Exp Neurol, 182, 261, 10.1016/S0014-4886(03)00116-X Yang, 2014, An integrated stroke model with a consistent penumbra for the assessment of neuroprotective interventions., Eur Neurol, 71, 4, 10.1159/000356048 Wojcik, 2011, Interleukin-6: a potential target for post-thrombotic syndrome., Ann Vasc Surg, 25, 229, 10.1016/j.avsg.2010.09.003 DeRoo, 2015, The role of galectin-3 and galectin-3-binding protein in venous thrombosis., Blood, 125, 1813, 10.1182/blood-2014-04-569939 Kita, 2012, Large infarct and high mortality by cerebral ischemia in mice carrying the factor V Leiden mutation., J Thromb Haemost, 10, 1453, 10.1111/j.1538-7836.2012.04776.x MacArthur, 2014, Guidelines for investigating causality of sequence variants in human disease., Nature, 508, 469, 10.1038/nature13127 Rodríguez de Córdoba, 1994, The gene coding for the beta-chain of C4b-binding protein (C4BPB) has become a pseudogene in the mouse., Genomics, 21, 501, 10.1006/geno.1994.1308 Maruyama, 2015, ELISA-based detection system for protein S K196E mutation, a genetic risk factor for venous thromboembolism., PLoS One, 10, e0133196, 10.1371/journal.pone.0133196 Liu Zhu, 2010, Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor., Blood, 115, 4963, 10.1182/blood-2010-01-262386 Zhong, 2010, Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region., J Neurosci, 30, 15521, 10.1523/JNEUROSCI.4437-10.2010 Griffin, 2015, Activated protein C: biased for translation., Blood, 125, 2898, 10.1182/blood-2015-02-355974 Abrams, 2011, Framing postpartum hemorrhage as a consequence of human placental biology: an evolutionary and comparative perspective., Am Anthropol, 113, 417, 10.1111/j.1548-1433.2011.01351.x